Received: 19 November 2021
Accepted: 3 March 2022
First Online: 1 April 2022
: The study was approved by King Abdullah International Medical Research Center (KAIMRC) with an Institutional Review Board (IRB) approval number (SP21J/129/03). All methods were performed in accordance with the relevant guidelines and regulations. The researchers clarified the purpose of the study and the participant’s right to refuse or withdraw at any time without affecting their classes or grades. The researchers obtained informed consent from participants to share in the study and ensured data privacy and confidentiality.
: Not Applicable.
: The authors declared no potential conflicts of interest.